| P/E (FY) | 38.9 | Sales (TTM) | DKK 22.97B |
| Earnings (TTM) | DKK 1.54B | ROE | 15.92% |
| Net Margin | 6.73% | ROIC | 12.28% |
| Debt / Equity | 1.79 | TD / EBITDA | — |
| EPS Growth 3Y | −7.41% | Sales Growth 3Y | 5.24% |
Demant is a hearing healthcare company active in Europe, North America, the Asia-Pacific region, and elsewhere. It develops, manufactures, and wholesales hearing aids; owns and operates hearing care clinics; and supplies hearing and balance assessment solutions used by audiologists, ENT physicians, and balance clinics. Formerly William Demant Holding, it adopted its current name in 2019 and is headquartered in Smørum, Denmark.
| Market Cap | $9.14B | Trading Days | 4087 |
| 52W High | 286.80 |
| 52W Low | 175.00 |
| % Off High | −0.91% |
| YTD | 32.06% | 1Y | 2.08% |
| 3Y | 5.26% | 5Y | −24.41% |
| 10Y | 108.82% | Since incept. (ann.) | 8.12% |
| Ann. Volatility (1Y) | 35.89% | Ann. Volatility (3Y) | 32.69% |
| Sharpe (1Y) | 0.24 | Sharpe (3Y) | 0.20 |
| Max Drawdown (1Y) | −36.53% | Max Drawdown (3Y) | −52.37% |
| Beta (3Y, vs SPY) | 0.79 |
No same-industry peers in the universe for DEMANT.CO.
